Multiple sclerosis (MS) patients with immunoglobulin gamma (IgG) oligoclonal bands (OCB)
in the cerebrospinal fluid (CSF) have different genetic backgrounds and brain MRI features …

Abstract Background Although IgG oligoclonal bands (OCBs) in the cerebrospinal fluid
(CSF) are a frequent phenomenon in multiple sclerosis (MS) patients, their relationship with …

Background: Immunoglobulin gamma (IgG) oligoclonal bands (OCB) in the cerebrospinal
fluid (CSF) are absent in a small group of multiple sclerosis (MS) patients. According to …

Background and purpose Cerebrospinal fluid (CSF) neurofilament light protein (NFL) is a
promising biomarker of axonal injury and neurodegeneration. Here CSF lymphocyte …

Objective To identify a biomarker distinguishing patients who, despite a primary progressive
multiple sclerosis (PPMS) clinical course, may nonetheless benefit from immune therapy …

Background: Prognostic markers are needed to guide multiple sclerosis (MS) management
in the context of large availability of disease-modifying drugs (DMDs). Objective: To …

Background: The use of oligoclonal bands (OCBs) and cerebrospinal fluid (CSF) parameters
are established in the diagnosis of MS, but poorly as markers of disease. Objective: To …

Introduction: Cerebrospinal fluid (CSF) oligoclonal bands (OB) imply intrathecal
immunoglobulin synthesis and B-cell immune process. There is scarce evidence of OB …

Oligoclonal IgG bands (OCGB) are characteristic of multiple sclerosis (MS). Most patients
show OCGB exclusively in cerebrospinal fluid (CSF). Others have serum bands with …

Importance Reliable biomarkers associated with disability worsening in multiple sclerosis
(MS) are still needed. Objective To determine a possible association of intrathecal IgG …